“…This focus may be due to the protracted time course, heterogeneity of disease progression, variable onset or prognosis, and complex care needs associated with chronic diseases. 1,2 Chronic neurologic conditions deserve attention from the CMMI due to their increasing prevalence and disproportionate socioeconomic impact on patients. For instance, the global prevalence of neurodegenerative diseases, like Alzheimer disease and Parkinson disease (PD), increased 117% and 145%, respectively, between 1990 and 2016.…”